Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity
Longitudinal transcriptional and histological profiling of SARS-CoV-2 infected golden hamsters maps a wave of inflammation that reaches tissues with little or no productive replication, and shows that intranasal type I interferon given before or after challenge lowers viral load and disease burden.